Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population

References

• AktasMKOzduranVPothierCEGlobal risk scores and exercise testing for predicting all-cause mortality in a preventive medicine programJAMA20042921462815383517
   PubMed Web of Science ®Google Scholar
• BarronHVHarrSDRadfordMJThe association between white blood cell count and acute myocardial infarction mortality in patients ≥65 years of age: findings from the cooperative cardiovascular projectJ Am Coll Cardiol20013816546111704377
   PubMedGoogle Scholar
• ConroyRMPyoralaKFitzgeraldAPEstimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEur Heart J200324987100312788299
   PubMed Web of Science ®Google Scholar
• DaneshJCollinsRApplebyPAssociation of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studiesJAMA19982791477829600484
   PubMed Web of Science ®Google Scholar
• DaneshJCollinsRPetoRLipoprotein(a) and coronary heart disease. Meta-analysis of prospective studiesCirculation20001021082510973834
   PubMed Web of Science ®Google Scholar
• DraguRHuriSZuckermanRPredictive value of white blood cell subtypes for long-term outcome following myocardial infarctionAtherosclerosis20061213 Epub ahead of print
   PubMedGoogle Scholar
• EmpanaJPDucimetierePArveilerDAre the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME StudyEur Heart J20032419031114585248
   PubMed Web of Science ®Google Scholar
• FalkEShahPKFusterVCoronary plaque disruptionCirculation199592657717634481
   PubMed Web of Science ®Google Scholar
• FalkEPathogenesis of atherosclerosisJ Am Coll Cardiol2006478 SupplC71216631513
   PubMed Web of Science ®Google Scholar
• FolsomARMaJEckfeldtJHLow serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study InvestigatorsAnn Epidemiol19955186917606307
   PubMedGoogle Scholar
• FolsomARWuKKRosamondWDProspective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) StudyCirculation199796110289286936
   PubMed Web of Science ®Google Scholar
• GillumRFMussolinoMEMadansJHCounts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up studyAnn Epidemiol2005152667115780773
   PubMed Web of Science ®Google Scholar
• GrimmRHJrNeatonJDLudwigWPrognostic importance of the white blood cell count for coronary, cancer, and all-cause mortalityJAMA1985254193274046122
   PubMed Web of Science ®Google Scholar
• HaimMBoykoVGoldbourtUPredictive value of elevated white blood cell count in patients with preexisting coronary heart disease: the Bezafibrate Infarction Prevention StudyArch Intern Med2004164433914980995
   PubMedGoogle Scholar
• HanssonGKInflammation, atherosclerosis, and coronary artery diseaseN Engl J Med200535216859515843671
   PubMed Web of Science ®Google Scholar
• HaqIURamsayLEYeoWWIs the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk menHeart19998140610220543
   PubMed Web of Science ®Google Scholar
• HenseHWSchulteHLowelHFramingham risk function overestimates risk of coronary heart disease in men and women from Germany – results from the MONICA Augsburg and the PROCAM cohortsEur Heart J2003249374512714025
   PubMed Web of Science ®Google Scholar
• HoffmanMBlumABaruchRLeukocytes and coronary heart diseaseAtherosclerosis20041721614709350
   PubMed Web of Science ®Google Scholar
• HorneBDAndersonJLJohnJMIntermountain Heart Collaborative Study Group: Which white blood cell subtypes predict increased cardiovascular risk?J Am Coll Cardiol20054516384315893180
   PubMed Web of Science ®Google Scholar
• JamesALKnuimanMWDivitiniMLAssociations between white blood cell count, lung function, respiratory illness and mortality: the Busselton Health StudyEur Respir J19991311151910414413
   PubMedGoogle Scholar
• KannelWBAndersonKWilsonPWWhite blood cell count and cardiovascular disease: insights from the Framingham StudyJAMA1992267125361538564
   PubMed Web of Science ®Google Scholar
• KirtaneAJBuiAMurphySAAssociation of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarctionAm J Cardiol200493532614996574
   PubMed Web of Science ®Google Scholar
• KullerLHTracyRPShatenJRelation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention TrialAm J Epidemiol1996144537478797513
   PubMed Web of Science ®Google Scholar
• LeeCDFolsomARNietoFJWhite blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities studyAm J Epidemiol20011547586411590089
   PubMed Web of Science ®Google Scholar
• LibbyPMolecular bases of the acute coronary syndromesCirculation1995912844507758192
   PubMed Web of Science ®Google Scholar
• LibbyPInflammation in atherosclerosisNature20024208687412490960
   PubMed Web of Science ®Google Scholar
• MadjidMAwanIWillersonJTLeukocyte count and coronary heart disease: implications for risk assessmentJ Am Coll Cardiol20044419455615542275
   PubMed Web of Science ®Google Scholar
• MargolisKLMansonJEGreenlandPLeukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women’s Health Initiative Observational StudyArch Intern Med2005165500815767524
   PubMed Web of Science ®Google Scholar
• MenottiAPudduPELantiMComparison of the Framingham risk function-based coronary chart with risk function from an Italian population studyEur Heart J2000213657010666350
   PubMed Web of Science ®Google Scholar
• McEwanPWilliamsJEGriffithsJDEvaluating the performance of the Framingham risk equations in a population with diabetesDiabet Med2004213182315049932
   PubMed Web of Science ®Google Scholar
• NasirKGuallarENavas-AcienARelationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999–2002Arterioscler Thromb Vasc Biol20052519667115976323
   PubMed Web of Science ®Google Scholar
• OlivaresRDucimetierePClaudeJRMonocyte count: a risk factor for coronary heart disease?Am J Epidemiol199313749538434572
   PubMed Web of Science ®Google Scholar
• PearsonTAMensahGAAlexanderRWMarkers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart AssociationCirculation200310749951112551878
   PubMed Web of Science ®Google Scholar
• PepysMBBergerAThe renaissance of C reactive proteinBMJ20013224511141130
   PubMedGoogle Scholar
• PrenticeRLSzatrowskiTPKatoHLeukocyte counts and cerebrovascular diseaseJ Chronic Dis1982a3570317107804
   PubMedGoogle Scholar
• PrenticeRLSzatrowskiTPFujikuraTLeukocyte counts and coronary heart disease in a Japanese cohortAm J Epidemiol1982b1164965097124717
   PubMed Web of Science ®Google Scholar
• PyoralaKAssessment of coronary heart disease risk in populations with different levels of riskEur Heart J2000213485010666347
   PubMed Web of Science ®Google Scholar
• RidkerPMC-reactive protein and risks of future myocardial infarction and thrombotic strokeEur Heart J199819139503166
   PubMedGoogle Scholar
• RossRThe pathogenesis of atherosclerosis: a perspective for the 1990sNature199336280198479518
   PubMed Web of Science ®Google Scholar
• RossRAtherosclerosis – an inflammatory diseaseN Engl J Med1999340115269887164
   PubMed Web of Science ®Google Scholar
• RoyDQuilesJAvanzasPA comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndromeInt J Cardiol20061093172116046018
   PubMedGoogle Scholar
• SwirskiFKLibbyPAikawaELy-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromataJ Clin Invest200711719520517200719
   PubMed Web of Science ®Google Scholar
• ThomsenTFMcGeeDDavidsenMA cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart StudyInt J Epidemiol2002318172212177028
   PubMed Web of Science ®Google Scholar
• TopolEJLauerMSThe rudimentary phase of personalised medicine: coronary risk scoresLancet20033621776714654312
   PubMedGoogle Scholar
• TraceyRPInflammation in cardiovascular disease: cart, horse, or both?Circulation199897200029610527
   PubMedGoogle Scholar
• WeissSTSegalMRSparrowDRelation of FEV1 and peripheral blood leukocyte count to total mortality. The Normative Aging StudyAm J Epidemiol19951424938 Discussion, 499–5037677128
   PubMed Web of Science ®Google Scholar
• WheelerJGMussolinoMEGillumRFAssociations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individualsEur Heart J20042512879215288155
   PubMed Web of Science ®Google Scholar
• WilsonPWD’AgostinoRBLevyDPrediction of coronary heart disease using risk factor categoriesCirculation1998971837479603539
   PubMed Web of Science ®Google Scholar
• YarnellJWBakerIASweetnamPMFibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studiesCirculation199183836441999035
   PubMed Web of Science ®Google Scholar
• ZalokarJBLeukocyte counts and coronary heart disease in a Japanese cohortAm J Epidemiol1983118611126637988
   PubMedGoogle Scholar